DIVA Laboratories, Ltd. (TPEX:4153)

DIVA Laboratories Revenue

DIVA Laboratories had revenue of 248.36M TWD in the quarter ending September 30, 2026, with 26.08% growth. This brings the company's total for the last twelve months to 946.04M, up 9.70% year-over-year. In the year 2025, DIVA Laboratories had annual revenue of 868.84M with 0.76% growth. That makes DIVA Laboratories the 31,649th largest company in the world by revenue and 1,602nd in Taiwan.

• Revenue (ttm): 946.04M
• Revenue Growth: +9.70%
• P/S Ratio: 1.88
• Revenue / Employee: 6.14M
• Employees: 154
• Market Cap: 1.77B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 864.05M 97.6%
• Overseas 21.43M 2.4%

Fiscal year ended Dec 31, 2025 See the full DIVA Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	868.84M	6.52M	0.76%
Dec 31, 2024	862.32M	-31.52M	-3.53%
Dec 31, 2023	893.84M	-55.36M	-5.83%
Dec 31, 2022	949.20M	236.97M	33.27%
Dec 31, 2021	712.23M	-24.69M	-3.35%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error